Niagen Bioscience, Inc. Common Stock
$3.835
USD
Last updated on --.
24h volume1.04M
24h highest4.0250 USD
24h lowest3.8150 USD
24h Price movement-0.65%
NAGE recent prices
24 Hours
-0.65%-$0.025
30 days
-20.76%-$1.005
60 days
-10.40%-$0.445
90 days
-24.06%-$1.215
Key data
Previous close3.8600 USD
Market cap298.67M USD
Volume1.04M
P/E ratio16.030000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.23000 USD
Net income (FY)18.64M USD
Revenue (FY)130.42M USD
Last report dateMay 6, 2026
About Niagen Bioscience, Inc. Common Stock
HeadquartersLOS ANGELES
Employees (FY)117.00
Revenue per employee (FY)1.11M USD
Net income per employee (FY)159.29K USD
Listed onNasdaq
NAGE conversion tables
 |  |
|---|---|
| 0.5 NAGE | 1.917 USD |
| 1 NAGE | 3.835 USD |
| 5 NAGE | 19.17 USD |
| 10 NAGE | 38.35 USD |
| |
|---|---|
| 0.5 USD | 0.13038 NAGE |
| 1 USD | 0.26076 NAGE |
| 5 USD | 1.303 NAGE |
| 10 USD | 2.607 NAGE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NAGE is trading at $3.835, -0.65% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NAGE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NAGE is currently trading at $3.835, -0.65% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NAGE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NAGE's P/E ratio is currently 16.030000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NAGE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NAGE's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
Niagen Bioscience, Inc. Common Stock's market cap is currently 298.67M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.04M
24h highest4.0250 USD
24h lowest3.8150 USD
24h Price movement-0.65%
Start trade with NAGE Perpetual
Sign up to trade